Mindblown: a blog about philosophy.
Earnings call: Acacia Research posts Q3 results, acquires stake in Benchmark Energy, and announces share repurchase program
Acacia Research Corporation reported its third quarter financial results for 2023, highlighting the acquisition of a majority stake in Benchmark Energy II LLC, a Texas and Oklahoma-based oil and gas company. The company also announced a new share repurchase program and a favorable jury award in a patent infringement case. However, Acacia’s Q3 revenues declined […]
Earnings call: ATA Creativity Global reports 14.1% rise in Q3 2023 net revenue, driven by portfolio training and research-based learning services
ATA Creativity Global reported a 14.1% increase in net revenue for the third quarter of 2023, primarily driven by a surge in portfolio training and research-based learning services. The company’s gross margin improved to 49.2%, and it managed to narrow its net loss to RMB7.3 million. This comes alongside an announcement of new educational initiatives […]
German budget sees more cash for Ukraine, green buildings, industry
By Holger Hansen BERLIN (Reuters) – A draft of Germany’s next budget would double military aid to Ukraine to 8 billion euros ($8.57 billion) in 2024 while also spending more to make buildings more energy efficient and shield industry from high electricity prices. Chancellor Olaf Scholz’s coalition has readied the draft budget at a time […]
Earnings call: Aspira Women’s Health reports Q3 growth, anticipates CMS approval
Aspira Women’s Health Incorporated reported a 9% increase in product revenues for the third quarter of 2023, driven by a 5% increase in the number of OvaSuite tests performed. The company is awaiting CMS approval for pricing changes, which it expects to apply to all Medicare beneficiaries starting in January 2024. As part of its […]
Earnings call: Aspira Women’s Health reports Q3 growth, anticipates CMS approval
Aspira Women’s Health Incorporated reported a 9% increase in product revenues for the third quarter of 2023, driven by a 5% increase in the number of OvaSuite tests performed. The company is awaiting CMS approval for pricing changes, which it expects to apply to all Medicare beneficiaries starting in January 2024. As part of its […]
Earnings call: Aspira Women’s Health reports Q3 growth, anticipates CMS approval
Aspira Women’s Health Incorporated reported a 9% increase in product revenues for the third quarter of 2023, driven by a 5% increase in the number of OvaSuite tests performed. The company is awaiting CMS approval for pricing changes, which it expects to apply to all Medicare beneficiaries starting in January 2024. As part of its […]
U.S. likely to retaliate against Amsterdam flight cuts, IATA head says
AMSTERDAM (Reuters) -U.S. authorities are likely to retaliate against the Dutch government’s decision to cut flights at Amsterdam’s Schiphol airport, probably limiting slots for Dutch airline KLM at U.S. airports, airline lobby group IATA said on Tuesday. “This decision is significantly more damaging than people have estimated,” International Air Transport Association (IATA) head Willie Walsh […]
U.S. likely to retaliate against Amsterdam flight cuts, IATA head says
AMSTERDAM (Reuters) -U.S. authorities are likely to retaliate against the Dutch government’s decision to cut flights at Amsterdam’s Schiphol airport, probably limiting slots for Dutch airline KLM at U.S. airports, airline lobby group IATA said on Tuesday. “This decision is significantly more damaging than people have estimated,” International Air Transport Association (IATA) head Willie Walsh […]
Earnings call: Asure Software posts robust Q3 2023 results, eyes breakout year in 2024
Asure Software (NASDAQ:ASUR), in its recent earnings call, reported a strong third quarter for 2023, with a 34% increase in revenue compared to the previous year. The company witnessed growth across its HR Compliance and AsureMarketplace business lines and anticipates these segments to contribute significantly to future revenues. Despite the IRS’s halt on processing Employee […]
Earnings call: Acorda Therapeutics reports Q3 2023 results, maintains guidance, and explores inhaled therapy collaborations
Acorda Therapeutics (NASDAQ:ACOR) announced in its Q3 2023 earnings call that INBRIJA U.S. net sales increased by 4% to $8.1 million compared to the same quarter in 2022. Despite a challenging forecasting environment due to the pandemic, the company maintains its 2023 guidance and continues to explore collaborations for inhaled therapies using its ARCUS technology. […]
Got any book recommendations?